Responses
Symposium on HIV and assisted reproductive technologies
Use of assisted reproductive technology to reduce the risk of transmission of HIV in discordant couples wishing to have their own children where the male partner is seropositive with an undetectable viral load
Compose a Response to This Article
Other responses
No responses have been published for this article.
Other content recommended for you
- View 1: Assisted conception in couples with HIV infection
- Should HIV discordant couples have access to assisted reproductive technologies?
- Genetic diversity of HIV in seminal plasma remains higher than in blood after short-term antiretroviral therapy
- Impact of a nutritional supplement (Impryl) on male fertility: study protocol of a multicentre, randomised, double-blind, placebo-controlled clinical trial (SUppleMent Male fERtility, SUMMER trial)
- Antiretroviral drug concentrations in semen of HIV-1 infected men
- Intracytoplasmic sperm injection (ICSI) versus conventional in vitro fertilisation (IVF) in couples with non-severe male infertility (NSMI-ICSI): protocol for a multicentre randomised controlled trial
- The effects of urethritis on seminal plasma HIV-1 RNA loads in homosexual men not receiving antiretroviral therapy
- Investigation and management of subfertility
- Risk of prostate cancer for men fathering through assisted reproduction: nationwide population based register study
- Assisted conception. I—General principles